Search - tctmd.com

Displaying 481 - 500 of 3138

Sort: Relevancy | Date

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation AHA 2023

Dapagliflozin in myocardial infarction without diabetes or heart failure

Presenter: Stefan James

November 14, 2023

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

News Conference News AHA 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

Todd Neale

November 13, 2023

News Conference News AHA 2023

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

Michael O'Riordan

November 12, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Presenter: Said hajouli

October 26, 2023

Presentation TCT 2023

Challenging Cases treated with DES+DCB Stent Platform

Presenter: Ricardo Costa

October 26, 2023

Presentation TCT 2023

ABILITY DIABETES GLOBAL RCT: Study Updates

Presenter: Marie-Claude Morice

October 26, 2023

Presentation TCT 2023

Tailored to treat diabetes: The gamechanger Envisolution Technology

Presenter: Alexandre Abizaid

October 26, 2023

Presentation TCT 2023

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Presenter: Roxana Mehran

October 26, 2023

Advertisement

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Dapagliflozin in myocardial infarction without diabetes or heart failure

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

FDA Grants Tirzepatide a New Indication for Obesity Management

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

FDA Approves Paradise Renal Denervation System: What Comes Next?

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Challenging Cases treated with DES+DCB Stent Platform

ABILITY DIABETES GLOBAL RCT: Study Updates

Tailored to treat diabetes: The gamechanger Envisolution Technology

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content